[Pulmonary invasive aspergillosis: value of treatment with intravenous amphotericin B administered in a triglyceride emulsion for parenteral usage].

Author: AndrèsE, BergeratJ P, LimacherJ M

Paper Details 
Original Abstract of the Article :
Pulmonary invasive aspergillosis is a frequent and poor prognosis complication of immuno-deficiency and prolonged neutropenia. Its treatment is usually based on amphotericin B (0.7 to 1 mg/kg/d) given as intravenous infusions for at least 2 months. This therapy is limited by the side-effects of the ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0248-8663(94)80028-6

データ提供:米国国立医学図書館(NLM)

Intravenous Amphotericin B in a Triglyceride Emulsion for Pulmonary Invasive Aspergillosis

This case report highlights the successful treatment of [pulmonary invasive aspergillosis] using [intravenous amphotericin B] administered in a [triglyceride emulsion]. The patient, a woman with [pulmonary invasive aspergillosis], experienced [transient reduction in creatinine clearance with increased kaliuria] as the primary side effect.

A New Approach to Managing Invasive Aspergillosis

This case report demonstrates the potential of [intravenous amphotericin B] in [triglyceride emulsion] for managing [pulmonary invasive aspergillosis]. While further research is needed to assess its efficacy and safety, this study provides a promising alternative to traditional treatment methods.

Navigating the Treatment Options for Invasive Aspergillosis

Healthcare professionals facing [pulmonary invasive aspergillosis] will find this case report informative. It underscores the importance of exploring diverse treatment options, particularly in cases where conventional therapies are limited by side effects.

Dr.Camel's Conclusion

This case report showcases a novel approach to treating [pulmonary invasive aspergillosis] with [intravenous amphotericin B] in a [triglyceride emulsion]. Like a camel adapting to harsh desert conditions, this research explores new pathways towards more effective and less toxic treatment strategies for [pulmonary invasive aspergillosis].

Date :
  1. Date Completed 1994-09-09
  2. Date Revised 2019-08-25
Further Info :

Pubmed ID

8059144

DOI: Digital Object Identifier

10.1016/s0248-8663(94)80028-6

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.